In routine practice, molecular forms of breast cancer are defined on the basis of immunohistochemical examination, assessing the expression of the following proteins: estrogen receptor (ER), progesterone receptor (PR), and HER2 receptor [6,7]. Here, ESR1 is linked to breast carcinoma.